World

Russian Drone Strike Destroys Indian-Run Kusum Pharma Plant in Ukraine, Leaving One Dead and Causing ₹400 Crore Damage

By GS Team
4 Oct 20262 mins read
TukuTouch Logo
Indian Kusum Group's pharmaceutical plant in Sumy, Ukraine, was largely destroyed by Russian drone strikes, killing one and injuring several. The attack caused an estimated Rs 400 crore loss, severely disrupting the Indian-led company's operations and global supply of over 50 generic medicines across nine nations, including Ukraine, Uzbekistan, and the Philippines.

Summarized by AI; it may make mistakes. Check important info

Russian Drone Strike Destroys Indian-Run Kusum Pharma Plant in Ukraine, Leaving One Dead and Causing ₹400 Crore Damage
Representative Image

A major manufacturing facility belonging to India’s Kusum Group in Ukraine’s Sumy region has been largely destroyed following targeted Russian drone strikes, leaving one person dead and several others injured.

Footage from the scene captured massive plumes of thick black smoke rising from the burning facility. Officials warned that casualty numbers and the count of injured personnel could fluctuate as emergency operations continue at the damaged site.

Devastation at Sumy Manufacturing Hub

The drone strikes severely damaged the main structure of the pharmaceutical plant, dealing a heavy blow to the business operations of the Indian-run group in Eastern Europe. Initial estimates place the financial loss from the strike at a minimum of ₹400 crore.

Despite the ongoing conflict between Russia and Ukraine, the facility in Sumy had managed to maintain uninterrupted operations for years, making this direct hit a critical operational disruption.

Indian Enterprise in Ukraine's Healthcare Sector

Headquartered in India and led by Indian national Rajeev Gupta, the Kusum Group has deep ties to the Ukrainian market, describing itself as a Ukrainian entity with Indian roots:

  • Origins: The group began operations in 1994 as a distributor exporting medicines manufactured in India to Ukraine.
  • Transition: By 2002, the company phased out third-party distribution to focus exclusively on marketing its own proprietary brands.
  • Manufacturing Expansion: Kusum opened its first production unit in India in 2007, followed by the launch of the Sumy plant in Ukraine in 2009. The group subsequently established two additional plants in India.

Global Distribution and Supply Impact

The Kusum Group manufactures over 50 mostly generic pharmaceutical products. Its output serves critical healthcare markets across more than nine nations, primarily supplying Ukraine, Uzbekistan, Kazakhstan, and the Philippines. Authorities are assessing the full extent of the destruction and monitoring the medical status of the injured workers.